8 results
Evaluation of Lymphadenopathy - Localized vs Generalized #Diagnosis #EM #IM #Honc #Lymphadenopathy #Localized #Generalized #Infectious #Malignancy
Evaluation of Lymphadenopathy ... Generalized #Diagnosis #EM ... Generalized #Infectious #Malignancy ... #Differential #Algorithm
Algorithm for the Evaluation and Management of Transfusion Reactions

This algorithm was developed by Dr. Eric Madden,
Algorithm for the ... Evaluation and ... Reactions This algorithm ... at McGovern Med EM ... Diagnosis #Management #Hematology
Age-Focused Initial Evaluation for Pyoderma Gangrenosum 

All Patients: 
 - A thorough history and physical examination
Age-Focused Initial Evaluation ... examination focused on associated ... Age-appropriate malignancy ... Gangrenosum #Workup #Evaluation ... #Age #Dermatology
Differential Diagnosis of Hypoglycemia
Evaluation of Hypoglycemia
Patients with known diabetes who are not systemically ill and can
of Hypoglycemia Evaluation ... antibodies #Diagnosis #EM ... #Differential #Algorithm ... #Drugs #Malignancy
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
stratification algorithm ... treatment of cancer-associated ... evidence in cancer-associated ... #DOAC #VTE #Malignancy ... #Cancer #Algorithm
â–º
Maculopapular Rashes - THE ALGORITHMIC APPROACH 

The term maculopapule is a portmanteau, a combination
of macule and
Maculopapular Rashes - THE ALGORITHMIC ... pathognomonic for SJS or EM ... require emergent evaluation ... #Diagnosis #Dermatology ... Maculopapular #Rash #Algorithm
Petechial/Purpuric Rashes- THE ALGORITHMIC APPROACH 

These rashes can be especially challenging and are
associated with devastating differential
Purpuric Rashes- THE ALGORITHMIC ... challenging and are associated ... ; however, an algorithmic ... require emergent evaluation ... #Diagnosis #Dermatology
Myelodysplastic syndromes current treatment algorithm 2018.

From Blood Cancer Journal, Published 24 May 2018

Myelodysplastic syndromes (MDS) are
current treatment algorithm ... risk of clonal evolution ... reduce disease-associated ... HFE mutations associated ... #algorithm #hematology